Leaderboard

En | De
No articles selected!     View Cart  
You are here: Urology-Nephrology » Neoplasia/BPH 14. May 2026
Search
medline.ch
Neoplasia/BPH
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 9392  Previews Next
   
   Articles 1 - 20 / 187828  
   
Not all masses are metastases: a diagnostic dilemma resolved - synchronous HER2-positive breast cancer and renal oncocytoma.
Int J Surg Case Rep
Shrivastava N, Mitra S, Pande S.
PMID: 42130550 [PubMed]


Plasmon-Enhanced Magnetic Fluorescent Nanoprobe for Ultrasensitive Detection of Urinary miRNA-96 Enabling Early Diagnosis and Risk Stratification of Bladder Cancer.
Anal Chem
Zhang D, Li M, Yang B, Yan Z, Ding C, Huang Y.
PMID: 42130209 [PubMed - as supplied by publisher]


Exploring the Efficacy of Immunotherapy in Combination with Surgical Resection in High-risk Muscle-invasive Bladder Cancer.
Iran J Allergy Asthma Immunol
Li Z, Liu C, Wang H.
PMID: 42130139 [PubMed - indexed for MEDLINE]


Rezvilutamide in combination with androgen deprivation therapy (ADT) with or without docetaxel in the neoadjuvant treatment of oligometastatic prostate cancer (REDOOM): study protocol for an open-label, parallel-cohort, multicentre clinical study.
BMJ Open
Chen ZJ, Zhu XX, Huang H, Ding YZ, Zhuang YD, Wang L, Li P, Yu KY, Chen HD, Wang HL, Li HY, Cai B, Deng ZX, Pan Y, Yang Y, Li P, Huang KT, Ji XW, Lin Q, Chen W.
PMID: 42129992 [PubMed - indexed for MEDLINE]


Bladder cancer segmentation using u-net-based deep-learning.
Sci Rep
Patil B, Hadjiiski L, Sun D, Chan HP, Cohan RH, Caoili EM, Zhou C.
PMID: 42129500 [PubMed - as supplied by publisher]


The impact of tissue detection on diagnostic artificial intelligence algorithms in prostate digital pathology.
Sci Rep
Boman SE, Mulliqi N, Blilie A, Ji X, Szolnoky K, Gudlaugsson E, Janssen EAM, Kjosavik SR, Asenjo J, Gambacorta M, Libretti P, Braun M, Kordek R, , Hotakainen K, Väre P, Pedersen BG, Sørensen KD, Ulhøi BP, Egevad L, Kartasalo K.
PMID: 42129415 [PubMed - indexed for MEDLINE]


Decoding the Raf-Mek-Erk-Rsk pathway in prostate cancer: from molecular mechanisms to clinical opportunities.
Br J Cancer
Waldron NR, Silva D, Westaby D, Jiménez-Vacas J, Taylor J, Sharp A.
PMID: 42129337 [PubMed - as supplied by publisher]


Diabetes mellitus and health-related quality of life in long-term survivors of breast, colorectal or prostate cancer: a population-based prospective study.
Br J Cancer
Yang K, Thong MSY, Doege D, Koch-Gallenkamp L, Weisser L, Bertram H, Eberle A, Holleczek B, Nennecke A, Waldmann A, Zeissig SR, Pritzkuleit R, Jansen L, Brenner H, Arndt V.
PMID: 42129336 [PubMed - as supplied by publisher]


Imaging-based clinical decision tree enables risk stratification of extraprostatic extension before radical prostatectomy in prostate cancer patients.
Insights Imaging
Hamm CA, Rüterhenke T, Baumgärtner GL, Mayerosch C, Schallenberg S, Lindholz M, Beetz NL, Asbach P, Penzkofer T.
PMID: 42129021 [PubMed]


Multi-institutional external validation of the European risk classification for high-grade Ta non-muscle-invasive bladder cancer.
World J Urol
Cournède M, Gabriel PE, Lottin M, Moschini M, Soria F, D'Andrea D, Shariat SF, Budowski A, Poyet C, Roumiguie M, Alvarez-Maestro M, Briganti A, Krajewski W, Hendricksen K, Veerman H, Afferi L, Mattei A, Di Bona C, Zamboni S, Simeone C, Thenault R, Verhoest G, Gontero P, Xylinas E.
PMID: 42128947 [PubMed - indexed for MEDLINE]


Outcomes of Intermediate Risk Non-muscle-invasive Bladder Cancer Receiving Adjuvant Treatment: A Pooled Analysis of Four Randomized Controlled Trials.
Eur Urol Oncol
Tan WS, Kamat AM, Lewis R, Porta N, Ackerman C, Vadiveloo T, Penegar S, Martini A, Vale L, Mostafid H, MacLennan G, Hall E, Heer R, Kelly JD.
PMID: 42128773 [PubMed - as supplied by publisher]


Salivary and serum microRNAs as noninvasive biomarkers for distinguishing prostate cancer from benign prostatic hyperplasia.
Am J Clin Pathol
Salehi M, Alaee M, Mousavi M, Panahi G, Goodarzi D, Amri J.
PMID: 42128534 [PubMed - indexed for MEDLINE]


First-in-human single-cell and TCR atlas reveals peripheral immune remodeling before and after irreversible electroporation in prostate cancer.
J Immunother Cancer
Xiang JC, Xia ZY, Sun JX, Ye GC, Wang Y, Yang J, Wang SG, Xia QD.
PMID: 42128518 [PubMed - indexed for MEDLINE]


Paraganglioma of the urinary bladder with a novel variant of SDHB mutation.
BMJ Case Rep
Shivani ZA, Puthalath RT.
PMID: 42128441 [PubMed - indexed for MEDLINE]


Nectin4-targeted molecular imaging for precise endoscopic diagnosis and image-guided surgery in bladder cancer.
Cell Rep Med
He Y, Guo H, Wang B, Gao W, Deng Y, Zhao Y, He K, Liang X, Tian J, Wang J, Li X, Du Y.
PMID: 42127904 [PubMed - as supplied by publisher]


Linguistic explicitness and lay‑adapted translation in health communication: A randomized controlled trial of prostate cancer screening communication among elderly Chinese males.
Patient Educ Couns
Shan Y, Ji M, Xu X, Xing Z, Dong Z.
PMID: 42127712 [PubMed - as supplied by publisher]


Semen RNA-Based Biomarkers for Prostate Cancer Detection and Risk Stratification: A Prospective Multi-Center Validation Study.
J Urol
Whitney DH, Clay M, Wipperfurth J, Wylie D, Shore ND, D'Anna R, Saltzstein D, Little K, Nabian M, Hovelson DH, Breunig E, Brawer M, Tyra L, Zutz T, Jarrard D.
PMID: 42127322 [PubMed - as supplied by publisher]


Correction: Berezowski et al. Biomarkers in Renal Cell Carcinoma: A Systematic Review and Immunohistochemical Validation Study. Cancers 2025, 17, 2588.
Cancers (Basel)
Berezowski B, Boothe R Jr, Chaplin B, Del Vecchio SJ, Fares Z, Humphries TLR, Ng KL, Noonan T, Samaratunga H, Urquhart A, Vesey DA, Wood ST, Gobe GC, Ellis RJ.
PMID: 42126826 [PubMed]


MRI radiomics predicting cribriform growth informs active surveillance decision in intermediate-risk prostate cancer.
Eur Radiol Exp
Fernandez Salamanca M, Simões R, Der, Pais Pooch E, van Leeuwen PJ, van der Poel HG, Guimaraes MAS, van der Heide UA, Schoots IG.
PMID: 42126787 [PubMed - indexed for MEDLINE]


NeuroSAFE-guided robot-assisted radical prostatectomy versus standard RARP: systematic review and meta-analysis of comparative studies.
J Robot Surg
Suartz CV, Micheleto JPC, Condotta BE, Schumacher LB, Galhardo KA, Azevedo MFD, Brito PHS, Chade D, Mota JM, Dener MC, Talizin TB, Sharour W, Shabana W, Lopes RI, Wettstein M, Elkoushy M, Nahas WC, Melão BVLA, de Almeida Luz M, Reis LO, de Bessa Junior J, De Carvalho Fernandes R, Filho LAR.
PMID: 42126466 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 187828    Page 1 of 9392  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1